DAB.bio Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

DAB.bio General Information

Description

Developer of bioreactor technology designed to facilitate the fermentation process. The company's technology combines processes of fermentation and the separation of the extracted components in one vessel, making products more affordable and competitive, enabling businesses to reduce their overall operational costs.

Contact Information

Website
www.dab.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Alexander Fleminglaan 1
  • 2613 AX Delft
  • Netherlands
+31 015
Primary Industry
Machinery (B2B)
Vertical(s)
Corporate Office
  • Alexander Fleminglaan 1
  • 2613 AX Delft
  • Netherlands
+31 015

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DAB.bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Feb-2021 Completed Generating Revenue
4. Later Stage VC (Series A) 23-May-2019 Completed Product In Beta Test
3. Accelerator/Incubator 01-Jan-2018 Completed Product In Beta Test
2. Corporate 01-Jul-2017 Completed Startup
1. University Spin-Out 01-Jan-2008 Completed Startup
To view DAB.bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

DAB.bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bioreactor technology designed to facilitate the fermentation process. The company's technology combines pr
Machinery (B2B)
Delft, Netherlands
37 As of 2024

Tokyo, Japan

Wallasey, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DAB.bio Competitors (2)

One of DAB.bio’s 2 competitors is Aspect (Machinery), a Corporation company based in Tokyo, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aspect (Machinery) Corporation Tokyo, Japan
Holiferm Venture Capital-Backed Wallasey, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

DAB.bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DAB.bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invest-NL (Investment Company) Impact Investing Minority
Mibiton Venture Capital Minority
FORWARD.one Venture Capital Minority
InnovationQuarter Venture Capital Minority
YES!Delft Accelerator/Incubator
You’re viewing 5 of 7 investors. Get the full list »

DAB.bio FAQs

  • When was DAB.bio founded?

    DAB.bio was founded in 2008.

  • Where is DAB.bio headquartered?

    DAB.bio is headquartered in Delft, Netherlands.

  • What is the size of DAB.bio?

    DAB.bio has 37 total employees.

  • What industry is DAB.bio in?

    DAB.bio’s primary industry is Machinery (B2B).

  • Is DAB.bio a private or public company?

    DAB.bio is a Private company.

  • What is DAB.bio’s current revenue?

    The current revenue for DAB.bio is .

  • How much funding has DAB.bio raised over time?

    DAB.bio has raised $2.24M.

  • Who are DAB.bio’s investors?

    Invest-NL (Investment Company), Mibiton, FORWARD.one, InnovationQuarter, and YES!Delft are 5 of 7 investors who have invested in DAB.bio.

  • Who are DAB.bio’s competitors?

    Aspect (Machinery) and Holiferm are competitors of DAB.bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »